Presentation NY Valves 2024 The Importance of Baseline Hemodynamics and Tricuspid Anatomy Presenter: Philipp Lurz June 07, 2024
Presentation NY Valves 2024 Real World TTVI Registries: Is There Concordance With the Randomized Trials? Presenter: Bassem M. Chehab June 07, 2024
Presentation NY Valves 2024 Transcatheter Tricuspid Valve Replacement - TRISCEND II Presenter: Raj Makkar June 07, 2024
Presentation NY Valves 2024 Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials Presenter: Nicolas M. Van Mieghem June 06, 2024
Presentation NY Valves 2024 Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO? Presenter: Samir R. Kapadia June 06, 2024
Presentation NY Valves 2024 Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry Presenter: Andrea Scotti June 06, 2024
Presentation NY Valves 2024 Surgical Mitral Valve Replacement With a Novel Polymeric Valve: 30-day Results From a Global Clinical Study of the Foldax TRIA Mitral Valve Presenter: Isaac George June 06, 2024
Presentation NY Valves 2024 Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy Presenter: Joao L. Cavalcante June 06, 2024
Presentation NY Valves 2024 T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial Presenter: Brian K. Whisenant June 06, 2024
Presentation NY Valves 2024 The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials? Presenter: Azeem Latib June 06, 2024
Presentation NY Valves 2024 Designing Trials to Assess the Effectiveness of New VHD Screening Strategies Presenter: Timothy Joseph Poterucha June 06, 2024
Presentation NY Valves 2024 Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do Presenter: Mauro Moscucci June 06, 2024
Presentation NY Valves 2024 Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients Presenter: Parag Goyal June 05, 2024
Presentation NY Valves 2024 Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials Presenter: Guillaume Bonnet June 05, 2024
Presentation NY Valves 2024 Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice Presenter: Amar Krishnaswamy June 05, 2024
Presentation NY Valves 2024 Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials Presenter: Rebecca T. Hahn June 05, 2024
Presentation NY Valves 2024 Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry Presenter: Neel Butala June 05, 2024
Presentation NY Valves 2024 Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial Presenter: Howard C. Herrmann June 05, 2024
Presentation NY Valves 2024 A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial Presenter: Ole De Backer June 05, 2024